Effect of Monitoring Continuous Glucose Levels and Physical Activity Via Wearables on Cardiovascular Risk Factors

Recruiting N/A Interventional Study
Coronary Heart Disease Physical Activity Cardiovascular Risk Factors
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
100 (estimated)
Sponsor
University Hospital, Basel, Switzerland · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The study aims to assess the effect of smart watches and continuous glucose measuring devices on cardiovascular risk factors.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Informed Consent signed by the subject * Completed outpatient cardiac rehabilitation * Diagnosis of coronary heart disease * Access to a smartphone for the duration of the study * 18 years or older on the date of consent Exclusion Criteria: * Diseases which limit physical ac…
Contacts

Jan Gerrit van der Stouwe, Dr. med.

+41 61 265 44 44

jangerrit.vanderstouwe@usb.ch

CONTACT

Patrick Badertscher, Dr. med.

+41 61 265 52 14

patrick.badertscher@usb.ch

CONTACT